Structure-based Drug Repositioning Explains Ibrutinib As VEGFR2 Inhibitor
PLoS ONE(2020)
Key words
Therapeutic Targets
AI Read Science
Must-Reading Tree
Example

Generate MRT to find the research sequence of this paper
Chat Paper
Summary is being generated by the instructions you defined